| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/21/2007 | EP1311482B1 Non-imidazole aryloxypiperidines as h3 receptor ligands |
| 02/21/2007 | EP1248605B1 Novel sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and methods of using them |
| 02/21/2007 | EP1224155B1 Novel bicyclic cannabinoid agonists for the cannabinoid receptor |
| 02/21/2007 | EP1212422B1 Human ctla-4 antibodies and their uses |
| 02/21/2007 | EP1189602B1 Morphine sulphate microgranules, method for preparing same and compositions containing same |
| 02/21/2007 | EP1161524B1 CELLS COEXPRESSING AN AMYLOID PRECURSOR PROTEIN AND AN $g(a)-SECRETASE AND THEIR USES IN TEST METHODS AND DIAGNOSTICS |
| 02/21/2007 | EP1140128B2 Method of using steam ironing of fabrics as a way of causing reduction of physiological and/or subjective reactivity to stress in humans |
| 02/21/2007 | EP1133474B1 3-substituted-4-arylquinolin-2-one derivatives as potassium channel modulators |
| 02/21/2007 | EP0894004B2 Method for enhancing functional recovery of motor coordination, speech or sensory perception after central nervous system ischemia or trauma |
| 02/21/2007 | CN1918180A Nogo-a neutralising immunoglobulins for treatment of neurological diseases |
| 02/21/2007 | CN1918167A Indoles, 1h-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof |
| 02/21/2007 | CN1918166A 烟碱乙酰胆碱受体配体 Nicotinic acetylcholine receptor ligands |
| 02/21/2007 | CN1918165A Azabicyclic heterocycles as cannabinoid receptor modulators |
| 02/21/2007 | CN1918164A Azabicyclic heterocycles as cannabinoid receptor modulators |
| 02/21/2007 | CN1918154A Poly-heterocyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 02/21/2007 | CN1918147A 1,2,3,4-tetrahydroisoquinoline derivatives, preparations thereof and uses thereof |
| 02/21/2007 | CN1918131A Novel inhibitors of glutaminyl cyclase |
| 02/21/2007 | CN1918129A Therapeutic agent |
| 02/21/2007 | CN1918128A Fused ring 4-oxopyrimidine derivative |
| 02/21/2007 | CN1918121A Pyrrole-3-carboxamide derivatives for the treatment of obesity |
| 02/21/2007 | CN1918118A Thioamide compound or its salt and cytokine production inhibitor containing the same |
| 02/21/2007 | CN1917921A Calcitonin gene related peptide receptor antagonists |
| 02/21/2007 | CN1917902A Use for interleukin-33 (il-33) and the il-33 receptor complex |
| 02/21/2007 | CN1917897A Composition and methods for modulating cns activity |
| 02/21/2007 | CN1917876A Methods and compositions |
| 02/21/2007 | CN1917860A Multiparticulate o-desmethylvenlafaxine salts and uses thereof |
| 02/21/2007 | CN1916017A Process for producing hydrophobic polypeptides, proteins or peptides. |
| 02/21/2007 | CN1916013A Pharmaceutical compounds |
| 02/21/2007 | CN1915994A Indole group alkaloid of sector Gouyahua, and application for preparing drug-breaking medicine |
| 02/21/2007 | CN1915993A Indole group alkaloid of Hainan Gouyahua, and application for preparing drug-breaking medicine |
| 02/21/2007 | CN1915981A 2-oxy-benzoxazinone derivatives for the treatment of obesity |
| 02/21/2007 | CN1915292A Application of acetylcholine esterase inhibitor medication of Yidancao extractive as cholinomimetic |
| 02/21/2007 | CN1915262A Preparation of Shuxiening injection, technique and adaptive disease |
| 02/21/2007 | CN1915233A Medicine composition for treating anxiety neurosis, and oral cavity disintegration preparation |
| 02/21/2007 | CN1915231A Use of nonsteroidal in preparing drug of antiinflammatory agents |
| 02/21/2007 | CN1915222A Composition of liposome, and preparation method |
| 02/21/2007 | CN1915216A New usage of tandospirone and its derivative, and composition containing tandospirone |
| 02/21/2007 | CN1301262C Method for producing glucolipid substance using ganglioside as main component |
| 02/21/2007 | CN1301255C Inhibitors of alpha l beta 2 integrin mediated cell adhesion |
| 02/20/2007 | US7179922 Chemical compounds |
| 02/20/2007 | US7179892 Humanized antibodies that recognize beta amyloid peptide |
| 02/20/2007 | US7179839 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction |
| 02/20/2007 | US7179835 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors |
| 02/20/2007 | US7179823 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 02/20/2007 | US7179821 Potassium/sodium channel blockers; for treatment of multiple sclerosis, spinal cord injury, traumatic brain injury, stroke, bladder irritation and dysfunction, neuropathic pain and chemokine-induced pain |
| 02/20/2007 | US7179815 For example, 3-[2(R)-{hydroxycarbonylpropyl-amino}-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methyl-pyrimidine-2,4(1H,3H)-dione; use in treating prostate cancer, benign prostatic hypertrophy, breast cancer and endometriosis |
| 02/20/2007 | US7179810 Phthalazinone-piperidino-derivatives as PDE4 inhibitors |
| 02/20/2007 | US7179807 5-substituted-2-arylpyrazines |
| 02/20/2007 | US7179804 Tachykinin receptor antagonists |
| 02/20/2007 | US7179802 reducing the risk of developing a condition selected from the group consisting of hypercholesterolemia, atherosclerosis, low HDL levels, high LDL levels, hyperlipidemia, hypertriglyceridemia and dyslipidemia |
| 02/20/2007 | US7179800 Cannabinoids |
| 02/20/2007 | US7179786 Variants of the NK1 fragment of hepatocyte growth factor/scatter factor (HGF/SF) and their use |
| 02/20/2007 | US7179627 Cyclooxygenase variants and methods of use |
| 02/20/2007 | US7179621 Pigment epithelium-derived factor: sequence of the PEDF gene |
| 02/20/2007 | US7179605 Characterizing the existence of a disease state; particularly to the utilization of mass spectrometry to elucidate particular biopolymer markers indicative or predictive of a particular disease state |
| 02/20/2007 | US7179496 Anti-depression pharmaceutical composition containing Polygala extract |
| 02/20/2007 | US7179491 Contacting marine oil with an effective amount of a silica under a vacuum;contacting the oil with an effective amount of a bleaching clay;separating the silica from the oil; and separating the clay from the oil |
| 02/20/2007 | US7179463 Treatment of alzheimer's disease |
| 02/20/2007 | CA2422374C Purine derivatives |
| 02/20/2007 | CA2371174C Cyclo-alkyl substituted benzimidazoles and their use as parp inhibitors |
| 02/20/2007 | CA2344574C Thyroid receptor ligands |
| 02/20/2007 | CA2335520C Adenosine derivatives |
| 02/20/2007 | CA2283929C Method for treating headache pain with topical local anesthetic compositions |
| 02/20/2007 | CA2186784C The use of carboxylic acid derivatives as drugs |
| 02/15/2007 | WO2007019417A1 Oxazolopyridine derivatives as sirtuin modulators |
| 02/15/2007 | WO2007019416A1 Benzimidazole derivatives as sirtuin modulators |
| 02/15/2007 | WO2007019346A1 Benzothiazoles and thiazolopyridines as sirtuin modulators |
| 02/15/2007 | WO2007019345A1 Imidazopyridine derivatives as sirtuin modulating agents |
| 02/15/2007 | WO2007019344A1 Imidazo [2,1-b] thiazole derivatives as sirtuin modulating compounds |
| 02/15/2007 | WO2007018998A2 Tricyclic benzimidazoles and their use as metabotropic glutamate receptor modulators |
| 02/15/2007 | WO2007018738A2 Fused bicycloheterocycle substituted quinuclidine derivatives |
| 02/15/2007 | WO2007018660A2 Gabaergic imidazobenzodiazepine derivatives to treat memory deficits |
| 02/15/2007 | WO2007018469A1 Oxopyridyl quinoline amides as nk3 receptor modulators |
| 02/15/2007 | WO2007018466A1 Alkylpyridyl quinolines as nk3 receptor modulators |
| 02/15/2007 | WO2007018465A1 Amide alkyl pyridiyl quinolines as nk3 receptor modulators |
| 02/15/2007 | WO2007018460A1 Therapeutic agents |
| 02/15/2007 | WO2007018459A1 Therapeutic agents |
| 02/15/2007 | WO2007018318A1 Method for gene expression specific to cerebellar astrocyte and/or basket cell |
| 02/15/2007 | WO2007018248A1 Pyridone compound |
| 02/15/2007 | WO2007018168A1 Acylguanidine derivative or salt thereof |
| 02/15/2007 | WO2007017914A2 Dermonecrotizing protein factors of bacterial origin and related uses in medical field |
| 02/15/2007 | WO2007017654A1 3, hb cis dihydrotetrabanezine for the treatment of schizophrenia and other psychoses |
| 02/15/2007 | WO2007017509A1 Compounds for the treatment of alzheimer's disease |
| 02/15/2007 | WO2007017507A1 Beta-secretase inhibitors for use in the treatment of alzheimer's disease |
| 02/15/2007 | WO2007017145A2 Gsk-3 inhibitors |
| 02/15/2007 | WO2007017139A1 Composition for moderating alcohol metabolism and for reducing the risk of alcohol induced diseases |
| 02/15/2007 | WO2007017058A1 Therapeutic combination comprising a nmda receptors blocker and a narcotic analgesic substance |
| 02/15/2007 | WO2007016955A1 Alcohol metabolism moderating composition |
| 02/15/2007 | WO2007016954A1 Composition for reducing drug or alcohol induced breast cancer risk |
| 02/15/2007 | WO2007016953A1 Composition for reducing alcohol induced liver cancer risk |
| 02/15/2007 | WO2007016952A1 Composition for reducing the risk of alcohol induced esophagenal and oropharyngolaryngeal cancer |
| 02/15/2007 | WO2007016951A1 Composition for reducing the risc of alcohol induced pancreatic cancer |
| 02/15/2007 | WO2007016950A1 Composition for reducing the risk of alcohol induced neurodegenerative disease |
| 02/15/2007 | WO2007016949A1 Composition for reducing the risc of alcohol induced neuropathy |
| 02/15/2007 | WO2006133242A3 Azinone and diazinone v3 inhibitors for depression and stress disorders |
| 02/15/2007 | WO2006131392A8 Pharmaceutical compositions of a neuroactive steroid and uses thereof |
| 02/15/2007 | WO2006103120A3 New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-alzheimer agents |
| 02/15/2007 | WO2006094811A3 Use of microtubule stabilizing compounds for the treatment of lesions of cns axons |
| 02/15/2007 | WO2006009975A3 Histamine to treat disorders affecting muscle function |
| 02/15/2007 | WO2005123703A8 Alkynyl derivatives as modulators of metabotropic glutamate receptors |